Embryo biopsy for doing PGS/PGT-A is still being promoted in leading journals of reproductive medicine.
It is our view that, to some degree, professional societies and journals should acknowledge a shared responsibility with the PGS/PGT-A laboratory community for having promoted PGS/PGT-A and that prominent members of the PGS/PGT-A laboratory community, with clear and not always disclosed commercial interests, have for years been cross-referencing and cross-reviewing each other's studies.
We feel that journal editors have not only allowed that to happen but have also fostered biased reporting in the literature by promoting many of these individuals through the review process, thereby allowing them to determine what was accepted for publication and what was rejected. Concomitantly, professional societies allowed those same interested parties to dominate the profession's conferences by excluding more skeptical voices.
PGS/PGT-A, the procedure should be banned outside of clinical study frameworks.
Read more at https://www.rbmojournal.com/article/S1472-6483(18)30330-4/fulltext